ID GYRB_MYCSM Reviewed; 675 AA. AC P0C559; P48355; Q59555; DT 10-JUL-2007, integrated into UniProtKB/Swiss-Prot. DT 10-JUL-2007, sequence version 1. DT 27-MAR-2024, entry version 83. DE RecName: Full=DNA gyrase subunit B {ECO:0000255|HAMAP-Rule:MF_01898}; DE EC=5.6.2.2 {ECO:0000255|HAMAP-Rule:MF_01898, ECO:0000269|PubMed:12000834}; GN Name=gyrB {ECO:0000255|HAMAP-Rule:MF_01898}; OS Mycolicibacterium smegmatis (Mycobacterium smegmatis). OC Bacteria; Actinomycetota; Actinomycetes; Mycobacteriales; Mycobacteriaceae; OC Mycolicibacterium. OX NCBI_TaxID=1772; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, ACTIVITY REGULATION, AND RP SUBUNIT. RC STRAIN=ATCC 27204 / DSM 43464 / SN2; RX PubMed=8574396; DOI=10.1099/13500872-141-12-3029; RA Madhusudan K., Nagaraja V.; RT "Mycobacterium smegmatis DNA gyrase: cloning and overexpression in RT Escherichia coli."; RL Microbiology 141:3029-3037(1995). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 607 / DSM 43465 / JCM 20379 / NBRC 3207 / NRRL B-692; RX PubMed=8733228; DOI=10.1111/j.1365-2958.1996.tb02617.x; RA Salazar L., Fsihi H., De Rossi E., Riccardi G., Rios C., Cole S.T., RA Takiff H.E.; RT "Organization of the origins of replication of the chromosomes of RT Mycobacterium smegmatis, Mycobacterium leprae and Mycobacterium RT tuberculosis and isolation of a functional origin from M. smegmatis."; RL Mol. Microbiol. 20:283-293(1996). RN [3] RP FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION, SUBUNIT, RP SUBCELLULAR LOCATION, AND DNA-BINDING. RC STRAIN=ATCC 27204 / DSM 43464 / SN2; RX PubMed=12000834; DOI=10.1093/nar/30.10.2144; RA Manjunatha U.H., Dalal M., Chatterji M., Radha D.R., Visweswariah S.S., RA Nagaraja V.; RT "Functional characterisation of mycobacterial DNA gyrase: an efficient RT decatenase."; RL Nucleic Acids Res. 30:2144-2153(2002). CC -!- FUNCTION: Supercoils relaxed DNA in an ATP-dependent manner CC (PubMed:8574396). A type II topoisomerase that negatively supercoils CC closed circular double-stranded (ds) DNA in an ATP-dependent manner to CC modulate DNA topology and maintain chromosomes in an underwound state, CC also catalyzes the interconversion of other topological isomers of CC double-stranded DNA rings, including catenanes (PubMed:12000834). At CC comparable concentrations has a stronger decatenation activity than CC E.coli, which is inhibited by ciprofloxacin and novobiocin CC (PubMed:12000834). Cleaves dsDNA at the sequence 5'-AT/GGCC-3', leaving CC a 4 base overhang (PubMed:12000834). Relaxes negatively supercoiled DNA CC in an ATP-independent manner (PubMed:12000834). CC {ECO:0000269|PubMed:12000834, ECO:0000269|PubMed:8574396}. CC -!- FUNCTION: Negative supercoiling favors strand separation, and DNA CC replication, transcription, recombination and repair, all of which CC involve strand separation. Type II topoisomerases break and join 2 DNA CC strands simultaneously in an ATP-dependent manner. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP-dependent breakage, passage and rejoining of double- CC stranded DNA.; EC=5.6.2.2; Evidence={ECO:0000255|HAMAP-Rule:MF_01898, CC ECO:0000269|PubMed:12000834}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|HAMAP- CC Rule:MF_01898, ECO:0000269|PubMed:12000834}; CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000255|HAMAP- CC Rule:MF_01898}; CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000255|HAMAP- CC Rule:MF_01898}; CC Note=Binds two Mg(2+) per subunit. The magnesium ions form salt bridges CC with both the protein and the DNA. Can also accept other divalent metal CC cations, such as Mn(2+) or Ca(2+). {ECO:0000255|HAMAP-Rule:MF_01898}; CC -!- ACTIVITY REGULATION: DNA supercoiling is inhibited by the coumarin CC antibiotic novobiocin (PubMed:8574396). Also inhibited by the CC fluoroquinolones ciprofloxacin and moxifloxacin (PubMed:12000834). CC {ECO:0000269|PubMed:12000834, ECO:0000269|PubMed:8574396}. CC -!- SUBUNIT: Heterotetramer, composed of two GyrA and two GyrB chains CC (PubMed:12000834, PubMed:8574396). In the heterotetramer, GyrA contains CC the active site tyrosine that forms a transient covalent intermediate CC with DNA, while GyrB binds cofactors and catalyzes ATP hydrolysis. CC {ECO:0000255|HAMAP-Rule:MF_01898, ECO:0000269|PubMed:12000834, CC ECO:0000305|PubMed:8574396}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_01898, CC ECO:0000269|PubMed:12000834}. CC -!- MISCELLANEOUS: Few gyrases are as efficient as E.coli at forming CC negative supercoils. Not all organisms have 2 type II topoisomerases; CC in organisms with a single type II topoisomerase this enzyme also has CC to decatenate newly replicated chromosomes. {ECO:0000255|HAMAP- CC Rule:MF_01898}. CC -!- SIMILARITY: Belongs to the type II topoisomerase GyrB family. CC {ECO:0000255|HAMAP-Rule:MF_01898}. CC -!- SEQUENCE CAUTION: CC Sequence=CAA63253.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X92503; CAA63253.1; ALT_INIT; Genomic_DNA. DR EMBL; X84077; CAA58884.1; -; Genomic_DNA. DR RefSeq; WP_003891333.1; NZ_UGQO01000001.1. DR PDB; 4BAE; X-ray; 2.35 A; A/B/C/D=19-212. DR PDB; 6Y8O; X-ray; 1.60 A; A/B=9-218. DR PDBsum; 4BAE; -. DR PDBsum; 6Y8O; -. DR AlphaFoldDB; P0C559; -. DR SMR; P0C559; -. DR BindingDB; P0C559; -. DR ChEMBL; CHEMBL3085613; -. DR DrugCentral; P0C559; -. DR GeneID; 66738197; -. DR OMA; QLWSTTM; -. DR GO; GO:0005694; C:chromosome; IEA:InterPro. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW. DR GO; GO:0034335; F:DNA negative supercoiling activity; IDA:UniProtKB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0006265; P:DNA topological change; IEA:UniProtKB-UniRule. DR GO; GO:0006261; P:DNA-templated DNA replication; IEA:UniProtKB-UniRule. DR CDD; cd16928; HATPase_GyrB-like; 1. DR CDD; cd00822; TopoII_Trans_DNA_gyrase; 1. DR Gene3D; 3.30.230.10; -; 1. DR Gene3D; 3.40.50.670; -; 1. DR Gene3D; 3.30.565.10; Histidine kinase-like ATPase, C-terminal domain; 1. DR HAMAP; MF_01898; GyrB; 1. DR InterPro; IPR002288; DNA_gyrase_B_C. DR InterPro; IPR011557; GyrB. DR InterPro; IPR003594; HATPase_C. DR InterPro; IPR036890; HATPase_C_sf. DR InterPro; IPR020568; Ribosomal_Su5_D2-typ_SF. DR InterPro; IPR014721; Ribsml_uS5_D2-typ_fold_subgr. DR InterPro; IPR001241; Topo_IIA. DR InterPro; IPR013760; Topo_IIA-like_dom_sf. DR InterPro; IPR000565; Topo_IIA_B. DR InterPro; IPR013759; Topo_IIA_B_C. DR InterPro; IPR013506; Topo_IIA_bsu_dom2. DR InterPro; IPR018522; TopoIIA_CS. DR InterPro; IPR006171; TOPRIM_domain. DR NCBIfam; TIGR01059; gyrB; 1. DR PANTHER; PTHR45866:SF1; DNA GYRASE SUBUNIT B, MITOCHONDRIAL; 1. DR PANTHER; PTHR45866; DNA GYRASE/TOPOISOMERASE SUBUNIT B; 1. DR Pfam; PF00204; DNA_gyraseB; 1. DR Pfam; PF00986; DNA_gyraseB_C; 1. DR Pfam; PF02518; HATPase_c; 1. DR Pfam; PF01751; Toprim; 1. DR PRINTS; PR01159; DNAGYRASEB. DR PRINTS; PR00418; TPI2FAMILY. DR SMART; SM00387; HATPase_c; 1. DR SMART; SM00433; TOP2c; 1. DR SUPFAM; SSF55874; ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase; 1. DR SUPFAM; SSF54211; Ribosomal protein S5 domain 2-like; 1. DR SUPFAM; SSF56719; Type II DNA topoisomerase; 1. DR PROSITE; PS00177; TOPOISOMERASE_II; 1. DR PROSITE; PS50880; TOPRIM; 1. PE 1: Evidence at protein level; KW 3D-structure; ATP-binding; Cytoplasm; DNA-binding; Isomerase; Magnesium; KW Metal-binding; Nucleotide-binding; Topoisomerase. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250" FT CHAIN 2..675 FT /note="DNA gyrase subunit B" FT /id="PRO_0000145324" FT DOMAIN 453..567 FT /note="Toprim" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01898" FT BINDING 459 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01898" FT BINDING 532 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /ligand_note="catalytic" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01898" FT BINDING 532 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01898" FT BINDING 534 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01898" FT SITE 484 FT /note="Interaction with DNA" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01898" FT SITE 487 FT /note="Interaction with DNA" FT /evidence="ECO:0000255|HAMAP-Rule:MF_01898" FT CONFLICT 162 FT /note="G -> R (in Ref. 1; CAA58884)" FT /evidence="ECO:0000305" FT HELIX 24..28 FT /evidence="ECO:0007829|PDB:4BAE" FT HELIX 31..34 FT /evidence="ECO:0007829|PDB:4BAE" FT HELIX 39..58 FT /evidence="ECO:0007829|PDB:4BAE" FT STRAND 64..69 FT /evidence="ECO:0007829|PDB:4BAE" FT STRAND 73..79 FT /evidence="ECO:0007829|PDB:4BAE" FT STRAND 90..94 FT /evidence="ECO:0007829|PDB:4BAE" FT HELIX 95..101 FT /evidence="ECO:0007829|PDB:4BAE" FT HELIX 125..130 FT /evidence="ECO:0007829|PDB:4BAE" FT STRAND 132..141 FT /evidence="ECO:0007829|PDB:4BAE" FT STRAND 144..151 FT /evidence="ECO:0007829|PDB:4BAE" FT STRAND 159..163 FT /evidence="ECO:0007829|PDB:4BAE" FT STRAND 168..175 FT /evidence="ECO:0007829|PDB:4BAE" FT TURN 177..179 FT /evidence="ECO:0007829|PDB:4BAE" FT HELIX 187..200 FT /evidence="ECO:0007829|PDB:4BAE" FT STRAND 205..210 FT /evidence="ECO:0007829|PDB:4BAE" SQ SEQUENCE 675 AA; 74512 MW; 68A9B7F98BE07951 CRC64; MAAQKNNAPK EYGADSITIL EGLEAVRKRP GMYIGSTGER GLHHLIWEVV DNAVDEAMAG FATRVDVKIH ADGSVEVRDD GRGIPVEMHA TGMPTIDVVM TQLHAGGKFD GETYAVSGGL HGVGVSVVNA LSTRLEATVL RDGYEWFQYY DRSVPGKLKQ GGETKETGTT IRFWADPEIF ETTDYNFETV ARRLQEMAFL NKGLTIELTD ERVTAEEVVD DVVKDTAEAP KTADEKAAEA TGPSKVKHRV FHYPGGLVDY VKHINRTKTP IQQSIIDFDG KGPGHEVEIA MQWNAGYSES VHTFANTINT HEGGTHEEGF RAALTSVVNR YAKDKKLLKD KDPNLTGDDI REGLAAVISV KVAEPQFEGQ TKTKLGNTEV KSFVQKICNE QLQHWFEANP AEAKTVVNKA VSSAQARIAA RKARELVRRK SATDIGGLPG KLADCRSTDP SKSELYVVEG DSAGGSAKSG RDSMFQAILP LRGKIINVEK ARIDRVLKNT EVQSIITALG TGIHDEFDIS KLRYHKIVLM ADADVDGQHI STLLLTLLFR FMKPLVENGH IFLAQPPLYK LKWQRSEPEF AYSDRERDGL LEAGRAAGKK INVDDGIQRY KGLGEMDAKE LWETTMDPSV RVLRQVTLDD AAAADELFSI LMGEDVEARR SFITRNAKDV RFLDV //